Arthur Herbst to Adenocarcinoma
This is a "connection" page, showing publications Arthur Herbst has written about Adenocarcinoma.
Connection Strength
1.198
-
Factors associated with a lack of pap smear utilization in women exposed in utero to diethylstilbestrol. J Womens Health (Larchmt). 2015 Apr; 24(4):308-15.
Score: 0.074
-
Clear cell adenocarcinoma of the lower genital tract. Correlation of mother's recall of diethylstilbestrol history with obstetrical records. Cancer. 1990 Nov 15; 66(10):2215-20.
Score: 0.055
-
Clear cell adenocarcinoma of the vagina and cervix secondary to intrauterine exposure to diethylstilbestrol. Semin Surg Oncol. 1990; 6(6):343-6.
Score: 0.051
-
Pelvic exenteration in clear cell adenocarcinoma of the vagina and cervix. Gynecol Oncol. 1989 Sep; 34(3):413-6.
Score: 0.050
-
An evaluation of stage II vaginal clear cell adenocarcinoma according to substages. Gynecol Oncol. 1988 Sep; 31(1):56-64.
Score: 0.047
-
Cervical screening and general physical examination behaviors of women exposed in utero to diethylstilbestrol. J Low Genit Tract Dis. 2008 Apr; 12(2):111-7.
Score: 0.046
-
Local therapy in stage I clear cell adenocarcinoma of the vagina. Cancer. 1987 Sep 15; 60(6):1319-24.
Score: 0.044
-
Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix. An update. N Engl J Med. 1987 Feb 26; 316(9):514-6.
Score: 0.042
-
The effects in the human of diethylstilbestrol (DES) use during pregnancy. Princess Takamatsu Symp. 1987; 18:67-75.
Score: 0.042
-
Clear cell adenocarcinoma (CCA) of the vagina and cervix in association with pregnancy. Gynecol Oncol. 1986 Jun; 24(2):207-19.
Score: 0.040
-
Risk factors for the development of diethylstilbestrol-associated clear cell adenocarcinoma: a case-control study. Am J Obstet Gynecol. 1986 Apr; 154(4):814-22.
Score: 0.040
-
Persistence and distribution of estrogen receptor in advanced epithelial ovarian carcinoma after chemotherapy. Obstet Gynecol. 1985 Feb; 65(2):257-63.
Score: 0.037
-
Nuclear DNA content of clear cell adenocarcinoma of the vagina and cervix and its relationship to prognosis. Gynecol Oncol. 1983 Apr; 15(2):230-8.
Score: 0.032
-
Accuracy of three sampling technics for the diagnosis of endometrial cancer and hyperplasias. J Reprod Med. 1982 Oct; 27(10):622-6.
Score: 0.031
-
DES-related female genital changes. Semin Oncol. 1982 Sep; 9(3):341-8.
Score: 0.031
-
Clear cell adenocarcinoma and the current status of DES-exposed females. Cancer. 1981 Jul 15; 48(2 Suppl):484-8.
Score: 0.029
-
The current status of the DES-exposed population. Obstet Gynecol Annu. 1981; 10:267-78.
Score: 0.028
-
Epidemiologic aspects and factors related to survival in 384 Registry cases of clear cell adenocarcinoma of the vagina and cervix. Am J Obstet Gynecol. 1979 Dec 01; 135(7):876-86.
Score: 0.026
-
DES-associated clear cell adenocarcinoma of the vagina and cervix. Obstet Gynecol Surv. 1979 Nov; 34(11):844.
Score: 0.025
-
Assessment of three sampling technics to detect endometrial cancer and its precursors. A preliminary report. Acta Cytol. 1979 Sep-Oct; 23(5):353-9.
Score: 0.025
-
Prenatal diethylstilbestrol exposure and human genital tract abnormalities. Natl Cancer Inst Monogr. 1979 May; (51):25-35.
Score: 0.025
-
An analysis of 346 cases of clear cell adenocarcinoma of the vagina and cervix with emphasis on recurrence and survival. Gynecol Oncol. 1979 Apr; 7(2):111-22.
Score: 0.024
-
Complications of prenatal therapy with diethylstilbestrol. Pediatrics. 1978 Dec; 62(6 Pt 2):1151-9.
Score: 0.024
-
Pathology of prenatal diethylstilbestrol exposure. Pathol Annu. 1978; 13 Pt 1:201-16.
Score: 0.022
-
Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix. Am J Obstet Gynecol. 1977 May 01; 128(1):43-50.
Score: 0.021
-
Epidemiology of vaginal adenosis and adenocarcinoma associated with exposure to stilbestrol in utero. Cancer. 1977 Apr; 39(4 Suppl):1892-5.
Score: 0.021
-
Intrauterine diethylstilbestrol exposure and its consequences: pathologic characteristics of vaginal adenosis, clear cell adenocarcinoma, and related lesions. Arch Pathol Lab Med. 1977 Jan; 101(1):1-5.
Score: 0.021
-
Pathology of vaginal and cervical abnormalities associated with prenatal exposure to diethylstilbestrol (des). J Reprod Med. 1975 Jul; 15(1):13-18.
Score: 0.019
-
The significance of adenosis and clear-cell adenocarcinoma of the genital tract in young females. J Reprod Med. 1975 Jul; 15(1):5-11.
Score: 0.019
-
Vaginal and cervical abnormalities, including clear-cell adenocarcinoma, related to prenatal exposure to stilbestrol. Ann Clin Lab Sci. 1974 Jul-Aug; 4(4):222-33.
Score: 0.018
-
Clear-cell adenocarcinoma of the vagina and cervix in girls: analysis of 170 registry cases. Am J Obstet Gynecol. 1974 Jul 01; 119(5):713-24.
Score: 0.018
-
Exogenous hormones in pregnancy. Clin Obstet Gynecol. 1973 Dec; 16(4):37-50.
Score: 0.017
-
Clear-cell adenocarcinoma of the genital tract in young females. Registry report. N Engl J Med. 1972 Dec 21; 287(25):1259-64.
Score: 0.016
-
Stilbestrol-adenosis-carcinoma syndrome: geographic distribution. N Engl J Med. 1971 Sep 16; 285(12):691.
Score: 0.014
-
Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med. 1971 04 22; 284(15):878-81.
Score: 0.014
-
Adenocarcinoma of the vagina in adolescence. A report of 7 cases including 6 clear-cell carcinomas (so-called mesonephromas). Cancer. 1970 Apr; 25(4):745-57.
Score: 0.013
-
Primary carcinoma of the vagina. An analysis of 68 cases. Am J Obstet Gynecol. 1970 Jan 15; 106(2):210-8.
Score: 0.013
-
Topographic relation of cervical ectropion and vaginal adenosis to clear cell adenocarcinoma. Obstet Gynecol. 1982 Nov; 60(5):546-51.
Score: 0.008
-
Clear cell adenocarcinoma of the vagina and cervix in black females. J Natl Med Assoc. 1982 Jul; 74(7):639-43.
Score: 0.008
-
Diethylstilbestrol and other sex hormones during pregnancy. Obstet Gynecol. 1981 Nov; 58(5 Suppl):35S-40S.
Score: 0.007
-
Estrogen receptor and peroxidase activity in epithelial ovarian carcinomas. J Natl Cancer Inst. 1981 Aug; 67(2):307-18.
Score: 0.007
-
DES update. Interview by Arthur I. Holleb. CA Cancer J Clin. 1980 Nov-Dec; 30(6):326-32.
Score: 0.007
-
Evaluation and management of diethylstilbestrol-exposed offspring. Surg Clin North Am. 1978 Feb; 58(1):87-96.
Score: 0.006
-
Vaginal and cervical cancers and other abnormalities associated with exposure in utero to diethylstilbestrol and related synthetic hormones. Cancer Res. 1977 Apr; 37(4):1249-51.
Score: 0.005
-
Summary of the changes in the human female genital tract as a consequence of maternal diethylstilbestrol therapy. J Toxicol Environ Health Suppl. 1976; 1:13-20.
Score: 0.005
-
Vaginal adenosis and other diethylstilbestrol-related abnormalities. Clin Obstet Gynecol. 1975 Sep; 18(3):185-94.
Score: 0.005
-
Editorial: Problems in the examination of the DES-exposed female. Obstet Gynecol. 1975 Sep; 46(3):353-5.
Score: 0.005
-
Delayed disease as a consequence of fetal exposure to radiation, infection, and exogenous hormones. Clin Perinatol. 1974 Sep; 1(2):483-90.
Score: 0.004
-
Clear-cell adenocarcinoma of the vagina and cervix in young females: analysis of 37 tumors that persisted or recurred after primary therapy. Cancer. 1974 Sep; 34(3):606-14.
Score: 0.004
-
Cytology of clear-cell adenocarcinoma of genital tract in young females: review of 95 cases from the registry. Acta Cytol. 1974 Jul-Aug; 18(4):279-90.
Score: 0.004
-
Stilbestrol and vaginal cancer in young women. CA Cancer J Clin. 1972 Sep-Oct; 22(5):292-5.
Score: 0.004
-
Registry of clear-cell carcinoma of genital tract in young women. N Engl J Med. 1971 Aug 12; 285(7):407.
Score: 0.004
-
Immunocytochemical identification of estrogen receptor in ovarian carcinomas. Localization with monoclonal estrophilin antibodies compared with biochemical assays. Lab Invest. 1985 Sep; 53(3):349-61.
Score: 0.002